Skip to main content

Peptide Synthesis Service Market: Trends and Growth

Page 1

MA R K E T R E S E A R CH BR I E F I N G · 2 0 2 6 – 2 03 5

Peptide Synthesis Service Market Global Industry Analysis and Forecast (2026–2035) — GLP-1 demand is scaling a research service into a USD 30.0 Billion manufacturing industry

>4× expansion

USD 6.8B (2025) → USD 30.0B (2035)

$6.8B

$8.0B

$30.0B

15.8%

Market size, 2025

Estimated size, 2026

Forecast, 2035

CAGR, 2026–2035

Executive Summary

Market Share Leaders, 2025

A USD 22.0B absolute dollar opportunity opens

North America (region)

43%

between 2026 and 2035. GLP-1 driven GMP capacity, cyclic peptide

Custom Peptide Synthesis

47%

Solid-Phase Synthesis (SPPS)

68%

Pharmaceutical Companies

44%

discovery and conjugate chemistry drive the

structural shifts. North America leads (~43%); Asia-Pacific grows fastest at 19.3% CAGR.

Moderately consolidated: top five providers hold ~56% of validated GMP-SPPS capacity.

Industry Ecosystem 1 · Inputs

2 · Synthesis

3 · Quality

4 · End Users

Amino acids, reagents,

SPPS, LPPS, hybrid,

Purification, analytics,

Pharma, biotech,

equipment

enzymatic

GMP compliance

diagnostics, academia

Copyright © Next Move Strategy Consulting

01


MA R K E T S I Z E & S E G ME NT ATI O N

Revenue Quadruples to USD 30.0B by 2035 Global revenue forecast, USD Billion — expanding at a 15.8% CAGR (2026–2035)

+15.8% CAGR

30.00

2026 → 2035

25.87 22.34 19.29 16.66 14.39

8.00

6.80

2025

2026

9.26

2027

10.73

2028

12.42

2029

2030

2031

2032

2033

2034

2035

USD 22.0B

USD 2.45B

22.3% CAGR

Absolute dollar opportunity,

U.S. — dominant country, 2025

India — fastest-growing country

2026–2035

Segment Leadership vs. Momentum Segment

Largest share (2025)

Fastest growth (CAGR)

Service Type

Custom Synthesis — 47% ($3.2B)

GMP Manufacturing — 18.0%

Technology

Solid-Phase (SPPS) — 68% ($4.6B)

Enzymatic — 26.2%

Peptide Type

Linear — 60% ($4.1B)

Cyclic — 19.8%

Modification

Unmodified — 44% ($3.0B)

Conjugated — 21.3%

Purity Grade

Research Grade — 50% ($3.4B)

GMP Grade — 21.7%

Production Scale

Milligram — 38% ($2.6B)

Large-Scale — 24.7%

End User

Pharma Companies — 44% ($3.0B)

Animal Health — 23.3%

Copyright © Next Move Strategy Consulting

02


G R O W T H D R I V E R S & O P P O R T U N I T IE S

GLP-1 Demand Anchors a MultiEngine Growth Cycle Impact on market CAGR (2026–2035): six drivers lift growth; constrained GMP capacity is the main brake GLP-1 peptide therapeutic demand

+3.4%

Metabolic & oncology peptide pipeline

+2.6%

GMP-scale capacity investment by CDMOs

+2.2%

Cyclic & conjugated modality adoption

+1.8%

Regional capacity diversification

+1.3%

Custom peptide library demand

+0.9%

Constrained validated GMP-SPPS capacity

−1.6%

High reactor & purification capex

−1.1%

Consolidation of independent providers

−0.7%

Complex synthesis yield & purification

−0.5%

Regional Growth Opportunity Map 1 · North America ~43% share (USD 2.9B, 2025); U.S. at USD 2.45B

2 · Asia-Pacific

3

1

Highest regional CAGR 19.3%; India

4

2

22.3%

3 · Europe Bachem Building K; Corden ~EUR 1B expansion

4

4 · Middle East & LatAm Emerging GMP CDMOs for dual-sourcing

High-Growth Segments (CAGR 2026–2035)

26.2%

24.7%

23.3%

21.7%

21.3%

Enzymatic synthesis

Large-scale production

Animal health end users

GMP purity grade

Conjugated peptides

Whitespace for investors: enzymatic green-chemistry platforms · integrated peptide-drug conjugate capability · GMP-certified regional CDMOs

Copyright © Next Move Strategy Consulting

03


CO MP E T I T I V E S CE N A R IO

Validated Capacity Is the New Competitive Moat A moderately consolidated market where scale players and specialists compete on capacity and chemistry

~56%

~36%

USD 1.81B

GMP-SPPS capacity held by top

of manufacturers ran above 80%

Samsung Biologics–PolyPeptide

five providers

utilization (2025)

deal (2026)

Integrated process development & manufacturing →

Competitive Positioning Matrix

Key Strategic Moves LARGE-SCALE GMP MANUFACTURERS

Aug 2026 — CordenPharma completes

M&A

AmbioPharm acquisition (U.S. & Shanghai)

Bachem

PolyPeptide for ~USD 1.81B EXP

Corden Pharma JPT

2026 — Samsung Biologics to acquire

M&A

Apr 2026 — Bachem inaugurates Building K, Bubendorf

Samsung / PolyPeptide

SK pharmteco

EXP

Oct 2025 — SK pharmteco USD 6.1M cGMP kilo-scale SPPS, California

EXP

SK pharmteco USD 260M Sejong facility, eight production trains

GenScript

EXP

Corden Pharma ~EUR 1B peptide expansion, Basel region

Biomatik AnaSpec

SPECIALIZED RESEARCH-GRADE Validated commercial GMP capacity → (qualitative)

Key Market Players Bachem Holding AG

PolyPeptide Group AG

Corden Pharma Intl.

WuXi AppTec

GenScript Biotech

Thermo Fisher Scientific

Ajinomoto Bio-Pharma

SK pharmteco

ScinoPharm Taiwan

CPC Scientific

Neuland Laboratories

GL Biochem (Shanghai)

BCN Peptides

AnaSpec, Inc.

JPT Peptide Tech.

Bio-Synthesis, Inc.

ProteoGenix

AAPPTec LLC

Biomatik Corporation

LifeTein, LLC

Winning playbook: secure validated large-scale GMP capacity · automate SPPS · build conjugate & enzymatic chemistry · enter via M&A

Copyright © Next Move Strategy Consulting

04


L E T ' S CO N N E CT

Thank You Connect with our analysts for in-depth insights and strategic guidance on the Peptide Synthesis Service Market

Contact Us W T @

Inside the Full Report

Official Websitewww.nextm

▸ Forecasts across 7 segmentation axes, 2026–

sc.com

2035

Contact Number+1

▸ Company-level revenue & project-volume

857 758 5017

benchmarking ▸ Synthesis technology scalability assessment

Emailinfo@nextmsc

▸ Pipeline-driven end-user demand analysis

.com

Click here for the complete report → Follow Us gen-dedup-715139c1047dc50fc11e5ba8a5e8448d.png

LinkedIn

gen-dedup-a33c1d6ec6986994cdb6d06bff72aa8e.png

Facebook

gen-dedup-af43e746accf3f78490ae3e6600388bf.png

YouTube

gen-dedup-8b664938785682eb80c49ba39d9d2e85.png

Twitter

gen-dedup-ad7063d46eff26f2c1039a235c8d1328.png

Instagram

Peptide Synthesis Service Market Global Industry Analysis and Forecast (2026–2035)

Copyright © Next Move Strategy Consulting

05


Turn static files into dynamic content formats.

Create a flipbook
Peptide Synthesis Service Market: Trends and Growth by llll122222 - Issuu